NexGold Intersects 23.73 g/t Gold over 5.3 Metres and 24.65 g/t Gold over 2.2 Metres at the Goldboro Open Pit Gold Project

(TSX-V:NEXG),(OTC US:NXGCF),(OTCQX:NXGCF), TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) — NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company“) is pleased to provide additional drill results from a recently-completed 26,854-metre diamond drill program initially announced on January 22, 2025 at the Company's Goldboro Open Pit Gold Project (“Goldboro“) in Nova Scotia. The drill program […]

KVH Industries Reports Second Quarter 2025 Results

(NASDAQ:KVHI), MIDDLETOWN, R.I., Aug. 07, 2025 (GLOBE NEWSWIRE) — KVH Industries, Inc. (Nasdaq: KVHI), reported financial results for the quarter ended June 30, 2025 today. The company will hold a conference call to discuss these results at 9:00 a.m. ET today, which can be accessed at investors.kvh.com. Following the call, a replay of the webcast

Monte Rosa Therapeutics Announces Second Quarter 2025 Financial Results and Business Updates

(NASDAQ:GLUE), Phase 1 study of NEK7-directed molecular glue degrader (MGD) MRT-8102 underway, to investigate a potential novel therapeutic approach for treating inflammatory diseases driven by the NLRP3 inflammasome; initial readout anticipated in H1 2026 VAV1-directed MGD MRT-6160 advancing toward anticipated initiation of multiple Phase 2 studies in immune-mediated diseases Phase 1/2 study of GSPT1-directed MGD

Onex Reports Second Quarter 2025 Results

(TSX:ONEX), All amounts in U.S. dollars unless otherwise stated TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) — Onex Corporation (TSX: ONEX) today announced its financial results for the second quarter ended June 30, 2025. “Onex delivered a solid second quarter with growth in investing capital per share and continued momentum across our businesses,” said Bobby Le

Baker Hughes Completes Acquisition of Continental Disc Corporation

(NASDAQ:BKR), HOUSTON and LONDON, Aug. 07, 2025 (GLOBE NEWSWIRE) — Baker Hughes (NASDAQ: BKR), an energy technology company, announced Thursday it has completed its all-cash, $540 million acquisition of Continental Disc Corporation (CDC) from investment partnerships managed by Tinicum Incorporated. The transaction brings a complementary portfolio of products to Baker Hughes' existing valves product line,

Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance

(NasdaqGM:LGND), Second quarter performance driven by strong portfolio royalty revenue growth of 57% 2025 full year revenue guidance increased to $200 million – $225 million (previously $180 million – $200 million) and adjusted earnings per diluted share1 increased to $6.70 – $7.00 (previously $6.00 – $6.25) Conference call begins at 8:30 a.m. Eastern Time today

Lifetime Brands, Inc. Reports Second Quarter 2025 Financial Results

(NASDAQ:LCUT), Sales of $131.9 million TTM Adjusted EBITDA of $50.7 million Company Maintains Strong Liquidity Position GARDEN CITY, N.Y., Aug. 07, 2025 (GLOBE NEWSWIRE) — Lifetime Brands, Inc. (NasdaqGS: LCUT), a leading global designer, developer and marketer of a broad range of branded consumer products used in the home, today reported its financial results for

Abcourt Provides Sleeping Giant Project development Update

(TSX-V:ABI),(OTC US:ABMBF),(Other OTC:ABMBF), ROUYN-NORANDA, Canada, Aug. 07, 2025 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (“Abcourt” or the “Corporation“) (TSX Venture: ABI) (OTCQB: ABMBF) is pleased to provide an update on the ramp-up activities at the Sleeping Giant Project in Eeyou Istchee, Quebec. Pascal Hamelin, President and CEO of Abcourt, commented: “We had a very good

Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results

(NASDAQ:CGEM), CLN-978 program now actively enrolling across Phase 1 studies in systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and Sjogren's disease BCMA-directed bispecific T cell engager velinotamig in-licensed from Genrix Bio Zipalertinib REZILIENT1 pivotal results shared in oral presentation at ASCO 2025 and in Journal of Clinical Oncology; multiple new data sets across a range

Scroll to Top